Spruce Biosciences share price logo

Spruce Biosciences

NASDAQ: SPRB

$53.20

-0.66

(-1.23%)

Live

as on

Spruce Biosciences Stock Performance

as on September 19, 2026 at 5:04 am IST

  • Day's Low

    Day's High

    $51.80
    $53.49
    downward going graph

    2.63%

    Downside

    0.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.26
    $240.00
    downward going graph

    86.35%

    Downside

    351.13%

    Upside

    downward going graph

Spruce Biosciences share price movements today

Previous Close
$53.86
Open
$52.11
Volume
112.9K
Market Cap
$154.8M
Day's Low - High
$51.80 - $53.49
52 Week Low - High
$7.26 - $240.00

Spruce Biosciences Historical Returns

1 Month Return
+ 1.92 %
3 Month Return
+ 2.86 %
1 Year Return
+ 506.36 %
3 Year Return
-70.33 %
5 Year Return
-89.89 %

Spruce Biosciences Stock Fundamentals & Key Indicators

Check Spruce Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$154.8M

EPS (TTM)

-40.87

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.32

Industry PE ratio

-2.37

PEG Ratio

-0.019944927300410174

EBITDA

-48.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-123.53%

Spruce Biosciences Stock Valuation

Track how Spruce Biosciences P/E has moved over time to understand its valuation trends.

Spruce Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-4.80x)

December 31, 2021

Industry (-2.37x)

December 31, 2025

Today (-1.71x)

December 31, 2025

Highest (-0.33x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.71x

Spruce Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Spruce Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$154.8M-89.89%-1.320.00%0.00%
BUY$42.2B530.61%-22.230.00%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Spruce Biosciences Stock including INR - Dollar returns

The Spruce Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Spruce Biosciences investment value today

Current value as on today

₹6,54,407

Returns

₹5,54,407

(+554.41%)

Returns from Spruce Biosciences Stock

₹4,98,930 (+498.93%)

Dollar Impact

₹55,477 (+55.48%)

Analyst Recommendation on Spruce Biosciences Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Spruce Biosciences. Average target price of $147.88

Spruce Biosciences Share Price Target

Get share price movements and forecasts by analysts on Spruce Biosciences.

What analysts predicted

64.02%UPSIDE

Target Price

$147.88

Current Price

$53.2

Analyzed by

6 Analysts

Target

$147.88

Spruce Biosciences target price $147.88, a slight upside of 64.02% compared to current price of $53.2. According to 6 analysts rating.

Indian Investors' Interest in Spruce Biosciences Stock

Search interest for Spruce Biosciences Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

Spruce Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2
1
0
0
-
-
-
-
-
-
Gross Profit
2
1
0
0
-
-
-
-
-
-
Operating Income
-12
-10
-9
-24
-14
-2
-8
-11
-11
-16
EBITDA
-11
-9
-8
-23
-13
-2
-8
-14
-11
-14
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-9
-8
-23
-14
-2
-8
-14
-12
-16
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
-9
-8
-23
-14
-2
-8
-14
-12
-16
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Spruce Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
10
4
-
Gross Profit
0
0
-
-
-
10
4
-
Operating Income
-9
-13
-29
-42
-47
-51
-56
-36
EBITDA
-9
-13
-29
-41
-45
-47
-52
-38
Interest Expense
-
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-9
-13
-29
-42
-46
-47
-53
-38
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-9
-13
-29
-42
-46
-47
-53
-38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
0.00%

Spruce Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-9
-8
-23
-14
-2
-8
-14
-12
-16
Operating Cash Flow
-14
-11
-9
-20
-12
-8
-5
-6
-8
-22
Investing Cash Flow
-
-
-
-
-
-
-
-
0
0
Financing Cash Flow
0
0
0
0
0
0
0
44
13
64
Change in Cash
-15
-11
-9
-21
-13
-9
-5
38
5
42

Spruce Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-13
-29
-42
-46
-47
-53
-38
Operating Cash Flow
-8
-12
-27
-35
-41
-33
-55
-33
Investing Cash Flow
-
0
0
-79
23
55
-
-
Financing Cash Flow
-
12
181
0
0
49
-1
43
Change in Cash
-8
0
153
-114
-18
71
-57
10

Mutual Funds that own Spruce Biosciences Stock

Check out the Mutual Funds with significant holdings in Spruce Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.624423%
17946
Fidelity Concord Street Trust
0.350346%
10069
DFA INVESTMENT DIMENSIONS GROUP INC
0.013674%
393
VANGUARD VALLEY FORGE FUNDS
0.004175%
120

Global Institutional Holdings in Spruce Biosciences

Funds
Holdings
Vanguard
4.71%
iShares
3.58%
Dimensional
0.24%
SPDR
0.23%
Invesco
0.09%

Spruce Biosciences News & Key Events

  • img

    Today's Timeline - 08 October

    Thu, 02:02 AM

    -

    Spruce Biosciences announces $50M private placement to advance enzyme replacement therapy for Sanfilippo Syndrome Type B.

Insights on Spruce Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SPRB stock has moved up by 506.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 14.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 51.8% return, outperforming this stock by 122.1%

About Spruce Biosciences

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sleeping patterns. In addition, the company develops SPR202 for the treatment of Congenital Adrenal Hyperplasia (CAH), a chronic and potentially life-threatening rare disease with no cure. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize various pharmaceutical compounds. It also has a collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize Tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.
OrganisationSpruce Biosciences
Headquarters611 Gateway Boulevard, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEODr. Javier Szwarcberg M.D., M.P.H.
E-voting on sharesClick here to vote

Key Management of Spruce Biosciences

Name

Title

Dr. Kirk Ways M.D., Ph.D.

Director

Mr. Eric Jordan M.B.A.

Vice President of Marketing

Mr. Corwin Dale Hooks M.B.A.

Chief Commercial Officer

Ms. Saba Sile M.D.

Senior Vice President of Clinical Development

Dr. Adrian Quartel FFPM, M.D.

Chief Medical Officer

Mr. Michael G. Grey

Executive Chairman

Dr. Javier Szwarcberg M.D., M.P.H.

CEO & Director

Mr. Samir M. Gharib CPA, M.B.A.

President & CFO

Mr. Bruno Gagnon BPHARM, M.Sc.

Senior Vice President of Clinical Development Operations

Dr. Daven Mody M.B.A., Pharm.D.

Senior Vice President of Regulatory & Quality

FAQs

What is Spruce Biosciences share price today?

Spruce Biosciences share price today is $53.20 as on . Spruce Biosciences share today touched a day high of $53.49 and a low of $51.80.

What is the 52 week high and 52 week low for Spruce Biosciences share?

Spruce Biosciences share touched a 52 week high of $240.00 on and a 52 week low of $7.26 on . Spruce Biosciences stock price today i.e. is trending at $53.20,which is 77.83% down from its 52 week high and 632.78% up from its 52 week low.

What is Spruce Biosciences's market capitalisation today?

Spruce Biosciences market capitalisation is $0.00T as on .

How to invest in Spruce Biosciences Stock (SPRB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Spruce Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Spruce Biosciences Shares that will get you 0.0282 shares as per Spruce Biosciences share price of $53.20 per share as on September 18, 2026 at 11:34 pm IST.

What is the minimum amount required to buy Spruce Biosciences Stock (SPRB) from India?

Indian investors can start investing in Spruce Biosciences (SPRB) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Spruce Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Spruce Biosciences share’s latest price of $53.20 as on September 18, 2026 at 11:34 pm IST, you will get 0.1880 shares of Spruce Biosciences. Learn more about fractional shares .

What are the returns that Spruce Biosciences has given to Indian investors in the last 5 years?

Spruce Biosciences stock has given -89.89% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?